Colin Watts

Medicine & Life Sciences

1. Glioblastoma 100%
2. Glioma 78%
3. Brain Neoplasms 45%
4. Neoplasms 29%
5. Aminolevulinic Acid 26%
6. Survival 17%
7. Circulating Tumor DNA 16%
8. Meningioma 14%
9. Carmustine 14%
10. Pandemics 13%
11. Central Nervous System Neoplasms 13%
12. Epigenomics 12%
13. Systematic Reviews 11%
14. Heterografts 11%
15. asparaginylendopeptidase 11%
16. Cohort Studies 10%
17. Therapeutics 10%
18. Clinical Trial Protocols 9%
19. 5-hydroxymethylcytosine 9%
20. Clinical Trials 9%
21. Cell-Free Nucleic Acids 9%
22. Multiparametric Magnetic Resonance Imaging 9%
23. Brain 9%
24. Surgical Oncology 8%
25. Quality of Life 8%
26. Neuroglia 8%
27. Multimodal Imaging 8%
28. Diabetes Insipidus 8%
29. myelin basic protein 85-99 8%
30. Neurofibromatosis 1 7%
31. T-Lymphocyte Epitopes 7%
32. Health Care Outcome Assessment 7%
33. cucurbit(8)uril 7%
34. Drug Combinations 7%
35. Ireland 7%
36. Decision Making 7%
37. Neurosurgery 7%
38. ErbB Receptors 7%
39. DNA Methylation 7%
40. Hydrogels 7%
41. DNA Fragmentation 6%
42. Length of Stay 6%
43. Mitochondrial DNA 6%
44. Observational Studies 6%
45. Surgeons 6%
46. Cerebrospinal Fluid 6%
47. Adjuvant Chemotherapy 6%
48. Pharmaceutical Preparations 6%
49. Plasma Cells 6%
50. Quality Improvement 6%